Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOF-based Regimens in Chronic HCV Patients in China
CTR20191138Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ledipasvir, sofosbuvir, velpatasvir, sofosbuvir + velpatasvir + voxilaprevir in hepatitis C virus infection, sponsored by Gilead Sciences. Started Jul 2019; status: completed.
02
Drugs
ledipasvirsofosbuvirvelpatasvirsofosbuvir + velpatasvir + voxilaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20191138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191138.